| アブストラクト | INTRODUCTION: We investigated the risk of UTIs and complex UTIs associated with SGLT2 (sodium-glucose cotransporter-2) inhibitors in men, emphasizing older men at higher risk for voiding dysfunction. METHODS: Utilizing a pharmacovigilance case-noncase design, we analyzed VigiBase reports from 1967 to 2022 among male patients. VigiBase is a comprehensive global database for drug safety. Disproportionality analysis, which compares the frequency of reported adverse events for specific drugs against other drugs, was conducted using reporting odds ratio (ROR) and empirical Bayes estimator (EBE). Age was stratified at 65 years as a threshold for increased susceptibility to male voiding dysfunctions. Sensitivity analyses were performed to compare SGLT2 inhibitor with other diabetes medications and years 2013 to 2022. RESULTS: There were 484 UTIs (ROR 6.75 [95% CI: 6.17-7.39]; EBE 6.78) and 165 complex UTIs (ROR 8.09 [95% CI: 6.94-9.43]; EBE 8.60). In men under 65, there were 178 UTIs (ROR 6.82 [95% CI: 5.88-7.91]; EBE 6.99) and 65 complex UTIs (ROR 7.30 [95% CI: 5.71-9.32]; EBE 7.90). In men 65 and over, we found 153 UTIs (ROR 5.11 [95% CI: 4.35-5.99]; EBE 5.44) and 59 complex UTIs (ROR 8.79 [95% CI: 6.79-11.37]; EBE 9.60). Sensitivity analyses consistently showed significant signals. CONCLUSIONS: This study suggests an elevated risk for both UTIs and complex UTIs in men taking SGLT2 inhibitors, with a more pronounced risk for complex UTI in older men who may have benign prostatic hyperplasia-related voiding dysfunction. These findings highlight the need for a balanced approach in prescribing SGLT2 inhibitors, particularly in populations potentially more susceptible to UTIs. |
|---|
| ジャーナル名 | Urology practice |
|---|
| 投稿日 | 2024/9/6 |
|---|
| 投稿者 | Qian, Zhiyu; Song, Jonathan; Jones, Alyssa; Tao, Brian; Xiao, Boyuan; Labban, Muhieddine; Dagnino, Filippo; Stelzl, Daniel; Zurl, Hanna; Cole, Alexander P; Trinh, Quoc-Dien; Lerner, Lori B |
|---|
| 組織名 | Department of Urological Surgery, Brigham and Women's Hospital, Harvard Medical;School, Boston, Massachusetts.;Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard;Medical School, Boston, Massachusetts.;Department of Surgery, VA Boston Healthcare System, West Roxbury, Massachusetts.;Department of Surgery, Boston University School of Medicine, Boston,;Massachusetts. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39241010/ |
|---|
